|
| U.S. Brand
Names |
|
| Secretin-Ferring Powder |

|
|
| Generic
Available |
|
|
No |

|
|
| Pharmacological Index |
|
|
Diagnostic Agent |

|
|
| Use |
|
|
Diagnosis of Zollinger-Ellison syndrome, chronic pancreatic dysfunction, and
some hepatobiliary diseases such as obstructive jaundice resulting from cancer
or stones in the biliary tract |

|
|
| Pregnancy Risk
Factor |
|
|
Not established |

|
|
| Adverse
Reactions |
|
|
<1%:
Miscellaneous: Hypersensitivity reactions |

|
|
| Stability |
|
|
Unstable; should be used immediately after reconstitution, store in freezer
(-20°C) or store at 25°C for up to 3
weeks |

|
|
| Mechanism of
Action |
|
|
Hormone normally secreted by duodenal mucosa and upper jejunal mucosa which
increases the volume and bicarbonate content of pancreatic juice; stimulates the
flow of hepatic bile with a high bicarbonate concentration, stimulates gastrin
release in patients with Zollinger-Ellison syndrome |

|
|
| Pharmacodynamics/Kinetics |
|
|
Inactivated by proteolytic enzymes if administered orally
Peak output of pancreatic secretions: Within 30 minutes
Duration of action: At least 2 hours |

|
|
| Usual Dosage |
|
|
Potency of secretin is expressed in terms of clinical units (CU). I.V.:
Zollinger-Ellison: 2 CU/kg slow I.V. injection over 1 minute
|

|
|
| Administration |
|
|
Reconstitute with 7.5 mL of normal saline; do not shake; use
immediately by direct I.V. injection slowly over 1 minute |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
Patients should fast 12-15 hours before test |

|
|
| Nursing
Implications |
|
|
Patients should fast 12-15 hours before test; reconstitute with 7.5 mL of
normal saline; do not shake; use immediately by direct I.V. injection
slowly over 1 minute
Monitor duodenal fluid volume and bicarbonate content; serum gastrin
(Zollinger-Ellison syndrome) |

|
|
| Dosage Forms |
|
|
Powder for injection: 75 units (10
mL) |

|
|
Copyright © 2007 Drugs Area
|